A customer operating in the Pharmaceuticals sector planned to introduce a high-value product to the Chinese market, where the risks associated with counterfeiting and parallel trade are particularly pronounced for Pharmaceuticals. To safeguard the integrity of this Pharmaceuticals product and to protect both brand reputation and patient safety, the company implemented an advanced anti-counterfeiting strategy specifically tailored to the Pharmaceuticals industry.
As part of this approach, the Pharmaceuticals products were equipped with high-security seals featuring unique, customized holograms combined with individual UIDs. These security elements enable full traceability across the Pharmaceuticals supply chain and provide a reliable method for authentication at every distribution stage. As a result, unauthorized diversion into gray markets can be detected at an early stage, and counterfeit Pharmaceuticals products can be unequivocally identified and removed from circulation, ensuring compliance with regulatory requirements and maintaining trust in the Pharmaceuticals brand.
